Objective To investigate the distribution and drug resistance of Chryseobacterium meningosepticum(CM)in our hospital.Methods The status of drug resistance of 73 strains of CM isolated from our hospital in the past 5 years was statistically analyzed.Metallo-β-lactamase producing isolates were screened by double-disk synergy test.Results The rate of metallo-β-laetamase producing Chryseobacterium meningosepticum(CM) accounted for 37.0%,which mainly distributed at intensive care unit(ICU).The resistant rates of CM clinical isolates to piperacillin/tazobactam,vancomycin and levofloxacin were 45.2%,40.6% and 28.5%,respectively.Conclusion CM displays multi-resistance to antibiotics.Antimicrobial agents should be selected rationally by clinicians according to antimicrobial susceptibility test results.